Human fibronectin extra domain B as a biomarker for targeted therapy in cancer.

Mol Oncol · 2020 · PMC7332215 · PMID 32386436

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

of borderline significanceno p-value reported

When patients were treated with IL‐19‐IL‐2 combined with dacarbazine, a median overall survival of borderline significance was seen at 419 days post‐treatment, relative to 325 days in patients treated with dacarbazine alone.

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.